Header Logo

Connection

BENJAMIN ARENKIEL to Bortezomib

Back to Details
This is a "connection" page, showing publications BENJAMIN ARENKIEL has written about Bortezomib.
BENJAMIN ARENKIEL
Connection Strength
0.018
Bortezomib
  1. Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatr Blood Cancer. 2009 Aug; 53(2):136-44.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.